Encompass Health Corporation
As of Oct 15, 2026 close
- Market cap
- $12.78B
- P/E (TTM)
- 20.57
- Forward P/E
- 17.53
- Dividend yield
- 0.61%
- 52-week range
- $92.77$127.99
- Volume (live)
- -
- Avg. volume (3M)
- 881.79K
Encompass Health (EHC) Stock Price & Financial Analysis
Encompass Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $127.50 - $129.96 |
|---|---|
| 52-Week High | $127.99 |
| 52-Week Low | $92.77 |
| Open | $128.74 |
| Volume (last close) | 1.11M |
| Average Volume (3M) | 881.79K |
| Revenue (TTM) | 6.21B |
|---|---|
| Net Income (TTM) | 621.00M |
| Free Cash Flow (TTM) | 413.40M |
| EPS (TTM) | $6.13 |
| Profit Margin | 10.01% |
| Operating Margin | 18.00% |
| Return on Equity (ROE) | 17.94% |
| Debt to Equity | 0.76 |
| Annual Dividend | $0.78 |
|---|---|
| Dividend Yield | 0.61% |
| Payout Ratio | 12.71% |
| Last Dividend Ex-Date | Oct 1, 2026 |
| Market Cap | 12.78B |
|---|---|
| Shares Outstanding | 100.00M |
| P/E Ratio (TTM) | 20.57 |
| Forward P/E | 17.53 |
| Price to Sales (P/S) | 2.06 |
| Price to Book (P/B) | 3.69 |
| EV/EBITDA | 10.29 |
| 50-Day MA | $122.17 |
|---|---|
| 200-Day MA | $108.83 |
| 1-Year Change | +3.88% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Encompass Health at a Glance
As of the Oct 15, 2026 close, Encompass Health (EHC) has a market capitalization of $12.78B. The stock trades at 20.6× trailing earnings, 17.5× forward earnings and 2.1× sales. Over the trailing twelve months it earned $621.00M on revenue of $6.21B (a 10.0% profit margin) and generated $413.40M of free cash flow. Revenue grew 9.5% year over year.
As of its latest reported balance sheet, it holds $107.70M in cash and securities against $2.63B of debt, a net debt position of $2.53B.
Encompass Health pays a quarterly dividend totaling $0.78 per share a year, a 0.61% yield at the Oct 15, 2026 close, with a 13% payout ratio and 2 consecutive years of dividend increases.
The share price is up 3.9% over the past year. At $127.77 (the Oct 15, 2026 close) it sits near the top of its 52-week range of $92.77 to $127.99, above its 200-day moving average of $108.83.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $146.78, 14.9% above the Oct 15, 2026 close.
Frequently Asked Questions About Encompass Health
What is the current stock price for EHC?
As of the Oct 15, 2026 close, EHC stock trades at $127.77. The 52-week range is $92.77–$127.99, with a day range of $127.50–$129.96.
What is the P/E ratio for EHC?
As of the Oct 15, 2026 close, Encompass Health's trailing twelve-month (TTM) P/E ratio is 20.6, meaning investors pay $20.6 for every $1 of annual earnings. The forward P/E is 17.5, reflecting analyst expectations for future earnings. Encompass Health operates in the Healthcare sector.
Does EHC pay dividends?
Yes, Encompass Health pays a 0.61% annual dividend yield as of the Oct 15, 2026 close ($0.78 per share a year). The trailing twelve-month payout ratio is 12.7%. The most recent ex-dividend date was October 1, 2026.
What do analysts recommend for EHC?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for EHC is Buy. The average 12-month price target is $146.78, a 14.9% upside from the Oct 15, 2026 close of $127.77.
What is the market cap of EHC?
As of the Oct 15, 2026 close, Encompass Health's market capitalization is $12.78B, classifying it as a large-cap company. Encompass Health operates in the Healthcare sector within the Medical Care Facilities industry.